Next Article in Journal
Anticancer and Immunogenic Properties of Cardiac Glycosides
Next Article in Special Issue
Natural Deep Eutectic Solvents (NADES) to Enhance Berberine Absorption: An In Vivo Pharmacokinetic Study
Previous Article in Journal
Recent Advances in the Synthesis of Spiroheterocycles via N-Heterocyclic Carbene Organocatalysis
Previous Article in Special Issue
Chokeberry Pomace as a Determinant of Antioxidant Parameters Assayed in Blood and Liver Tissue of Polish Merino and Wrzosówka Lambs
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessArticle
Molecules 2017, 22(11), 1923; doi:10.3390/molecules22111923

Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives

1,2,†
,
1,2,†
,
1,2
,
1,2
,
1,2
,
1,2
,
1,2
,
1,2
,
1,* and 1,2,*
1
State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China
2
The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 29 September 2017 / Revised: 1 November 2017 / Accepted: 5 November 2017 / Published: 8 November 2017
View Full-Text   |   Download PDF [1350 KB, uploaded 8 November 2017]   |  

Abstract

Twenty fangchinoline derivatives were synthesized from the natural product fangchinoline, and their anticancer activities on human breast cancer MDA-MB-231 cell line, human prostate cancer PC3 cell line, human melanoma WM9 cell line and human leukaemia HEL and K562 cell lines were evaluated. The biological result showed that those derivatives exhibited potent activities on inhibiting cancer cell growth, and the structure-activity relationships were investigated. Among them, compound 4g, which was protected by benzoyl group in 7-phenolic position and nitrified in 14-position, showed impressive inhibition on all 5 cancer cell lines, especially WM9 cell line, with an IC50 value of 1.07 µM. Further mechanistic studies demonstrated that compound 4g may induce cancer cell death by apoptotic means. These research results suggested that compound 4g could be a lead for the further development toward an anticancer agent against human melanoma WM9 in the future. View Full-Text
Keywords: fangchinoline; derivatives; anticancer activity; apoptosis fangchinoline; derivatives; anticancer activity; apoptosis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Liu, Y.; Xia, B.; Lan, J.; Hu, S.; Huang, L.; Chen, C.; Zeng, X.; Lou, H.; Lin, C.; Pan, W. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives. Molecules 2017, 22, 1923.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top